Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 31

Trial Status

Recruiting1

Role Distribution

Other Roles1

Activity Timeline

Clinical Trials (1)

NCT07869836Phase 3Recruiting
BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy
Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableBladder Ca+9 more
Studydirector

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Dr. Sandy Srinivas

Stanford University

Related
11 trials

Shared therapeutic areas:

Urinary Bladder CancerBladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Metastatic or Unresectable
Similarity Score8%

Lung-Ji Chang, PhD

Shenzhen Geno-Immune Medical Institute

Related
18 trials

Shared therapeutic areas:

Urinary Bladder CancerUrothelial Carcinoma Bladder
Similarity Score5%

Steven A Rosenberg, M.D.

National Cancer Institute (NCI)

Related
32 trials

Shared therapeutic areas:

Urinary Bladder CancerUrothelial Cancer
Similarity Score5%

Andrea B Apolo, M.D.

National Cancer Institute (NCI)

Related
12 trials

Shared therapeutic areas:

Urinary Bladder CancerUrothelial Cancer
Similarity Score5%

Jitendra Amlani, MD

Urocare Hospital

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Anish Thomas, M.D.

National Cancer Institute (NCI)

Related
9 trials

Shared therapeutic areas:

Urothelial Cancer
Similarity Score3%

Gustavo Leone

Medical University of South Carolina, Hollings Cancer Center

Related
12 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Sushil Bhatia, MD

Choithram Hospital and Research Centre

Related
2 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Yoshiya Yamada, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Laurence H. Klotz, MD

Toronto Sunnybrook Regional Cancer Centre

Related
5 trials

Shared therapeutic areas:

Urinary Bladder Cancer
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (1)

Showing 1 of 1 trials

NCT07869836Phase 3StudyDirector

BL-M07D1 (Trastuzumab Brengitecan T-bren) vs Standard of Care Platinum-based Chemotherapy (PBC) for HER2-expressing Metastatic Urothelial Cancer After Progression on Anti-PD-(L)1-based Therapy

Bladder (Urothelial, Transitional Cell) CancerBladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableBladder Ca+9 more
Recruiting

All 1 trials loaded